Radicava Now Approved Website May 8, 2017May 9, 2017 Brand: Radicava (edaravone), Intravenous Infusion Parent Company: MT Pharma America Drug Type: Prescription Drug Category: Rheumatology Campaign: now-approved Targeting: Patients Patient Website: https://www.radicava.com/patient/ HCP Website: https://www.radicava.com/hcp/ Homepage Homepage (Full View)